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Pumilio (Pum) is a translational repressor that binds selectively to targetmRNAs and recruits Nanos (Nos) as a corepressor. In the larval
neuromuscular system, Pum represses expression of the translation factor eIF-4E and the glutamate receptor subunit GluRIIA. Here, we
show that Nos, like Pum, is expressed at the neuromuscular junction (NMJ) and in neuronal cell bodies. Surprisingly, however, Nos and
Pumhave divergent functions onboth the presynaptic andpostsynaptic sides of theNMJ. Innosmutant andnosRNA interference larvae,
the number of NMJ boutons is increased, whereas loss of Pum reduces the bouton number. On the postsynaptic side, Nos acts in
opposition to Pum in regulating the subunit composition of the glutamate receptor. NMJ active zones are associated with GluRIIA- and
GluRIIB-containing receptor clusters. Loss ofNos causes downregulation of GluRIIA and increases the levels of GluRIIB. Consistentwith
this finding, the electrophysiological properties of NMJs lacking postsynaptic Nos suggest that they use primarily GluRIIB-containing
receptors. Nos can regulate GluRIIB in the absence of GluRIIA, suggesting that the effects of Nos on GluRIIB levels are at least partially
independent of synaptic competition between GluRIIA and GluRIIB. Nos is a target for Pum repression, and Pumbinds selectively to the
3 untranslated regions of the nos and GluRIIA mRNAs. Our results suggest a model in which regulatory interplay among Pum, Nos,
GluRIIA, and GluRIIB could cause a small change in Pum activity to be amplified into a large shift in the balance between GluRIIA and
GluRIIB synapses.
Introduction
Nanos (Nos) and Pumilio (Pum) are Drosophila translational
repressors that are required for pattern formation during early
embryonic development. Pum is a sequence-specific RNA-
binding protein that recruits Nos to target mRNAs. Maternally
synthesized Pum and Nos repress synthesis of the Hunchback
(Hb) transcription factor by binding to sites called Nanos re-
sponse elements (NREs) in the 3 untranslated region (UTR) of
hb mRNA (for review, see Kuersten and Goodwin, 2003). Pum
and Nos also bind to Cyclin B (CycB) mRNA in the germ cells.
Nos represses translation ofCycBmRNA by engaging a deadeny-
lase protein complex that removes its polyA tail (Kadyrova et al.,
2007). Repression of hbmRNA translation requires another core-
pressor, Brain Tumor (Brat) (Sonoda and Wharton, 2001),
which interacts with the translation initiationmachinery (Cho et
al., 2006). Pum is also likely to participate directly in repression,
because it is a member of the conserved family of Drosophilia
pumilio and Caenorhabditis elegans fem-3mRNA-binding factor
(PUF)-domain translational repressors, and PUF proteins can
interact with deadenylase/decapping complexes (Wickens et al.,
2002; Goldstrohm et al., 2006, 2007; Kadyrova et al., 2007).
Pum andNos have a variety of functions later in development
and appear to work together in most contexts. In the nervous
system, Pum represses expression of the Para sodium channel in
motor neurons and binds directly to para mRNA. Downregula-
tion of Para by Pum overexpression does not occur in a nosmu-
tant background, suggesting that para mRNA translation is re-
pressed by a Pum/Nos complex (Mee et al., 2004; Muraro et al.,
2008). Pum binds to a site in the 3UTR of mRNA for the
postsynaptic scaffolding protein Discs-large (Dlg), and Pum re-
presses Dlg in mushroom body neurons; Nos has not been as-
sayed in this system (Chen et al., 2008). pum and nos mutants
have the same dendritic branching phenotypes in the peripheral
nervous system (PNS), and alteration of branching by Nos over-
expression requires Pum (Ye et al., 2004). In contrast to these
examples, Nos and Pum are proposed to function separately in
maintenance of germline stem cells in the ovary (Forbes and
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Lehmann, 1998). The repression targets relevant to stem cell
maintenance have not been defined.
In this study, we analyze the functions of Nos at the larval
neuromuscular junction (NMJ), which is composed of glutama-
tergic synapses that use receptors related to the AMPA/kainate
family of ionotropic glutamate receptors. Because Nos is neces-
sary for translational repression of all known Pum targets, we had
anticipated that loss of Nos would produce phenotypes like those
we had previously defined for pummutants (Menon et al., 2004).
Our results, however, show that Nos and Pum act in opposition
to each other to regulate glutamate receptor subunit composition
and synaptic physiology. Pum represses expression of the Glu-
RIIA subunit of the receptor (Menon et al., 2004), whereas Nos
downregulates the alternative subunit GluRIIB. Pum also re-
presses Nos, so that Nos levels are increased when Pum levels go
down. Postsynaptic densities that containmostly GluRIIA recep-
tors allow more current flow in response to transmitter release
than do those that are dominated by GluRIIB receptors, and
GluRIIA and GluRIIB compete for synaptic occupancy (Petersen
et al., 1997; DiAntonio et al., 1999; Sigrist et al., 2002) [but see
Schmid et al. (2008) for an alternative view]. This regulatory
network, in which Pum represses Nos and GluRIIA, Nos re-
presses GluRIIB, and GluRIIA and GluRIIB antagonize each
other, could be used to convert small changes in Pum activity in
response to environmental conditions into major alterations in
the physiological properties of the NMJ.
Materials andMethods
Genetics
“Wild-type” flies usedwere eitherw1118 orWCS (w1118 crossed toCanton
S). nosRC, nosRD, and deficiency Df(3R)Dl-FX1 were obtained from R.
Wharton (Duke University, Durham, NC). Df(3R)Exel6183 was ob-
tained from the Exelixis collection at Harvard University (Boston, MA).
GAL4 drivers used in this study were muscle drivers C57-GAL4 (from V.
Budnik, University of Massachusetts, Amherst, MA), MHC-GAL4, and
24B-GAL4; the motor neuron driver OK6-GAL4 (from B. Burke and H.
Keshishian, Yale University, New Haven, CT); and the pan-neuronal
driver C155 (Elav)-GAL4. Controls for RNA interference (RNAi) and
overexpression experiments involving drivers werew1118 orWCS crossed
to the same driver. The Pum RNAi line was obtained from Vienna Dro-
sophila RNAi Center (Dietzl et al., 2007). GluRIIAAD9, GluRIIA and
GluRIIB deletions, SP22, and Dfcl-h4 were obtained from A. DiAntonio
(Washington University, St. Louis, MO).
Themuscle driverMHC-GeneSwitch-GAL4 213-3 on the second chro-
mosome (from T. Osterwalder and H. Keshishian, Yale University),
which has leaky expression in the absence of RU486 (Osterwalder et al.,
2001), was used in making the rescue line. The muscle rescue experi-
ments were done by crossing MHC-GeneSwitch GAL4 213-3/CyoActin-
GFP;nosRD/TM3 Serrate Actin-GFP to UAS-nos-tub3UTR/CyoActin-
GFP;Df(3R)Exel6183/TM3 Serrate Actin-GFP, and non-green
fluorescent protein (GFP) larvae were selected for analysis. All experi-
ments with nosmutants,muscle rescue lines, and corresponding controls
were done with crosses grown at 25°C. The control and experimental
crosses for nos RNAi and overexpression analyses were set up at 29°C.
To construct a plasmid containing a snapback nos transgene for RNAi
analysis, nos sequence fromnucleotide 744 to 1203 in exon 2was inserted
into the pWIZ vector on each side of the white intron according to pro-
tocols published by Lee andCarthew (2003).We selected two clones: one
with inserts oriented head to head and the other in tail-to-tail orienta-
tion. Plasmids were sequenced, and transgenic lines were made by stan-
dard techniques. The strongest RNAi phenotypes were seen for lines
containing the clone that had a tail-to-tail arrangement, as noted previ-
ously by Lee and Carthew (2003). We used two transgenic Nos RNAi
lines for the experiments in this study: a viable line on the second chro-
mosome and a lethal line on the third chromosome. Nos overexpression
was performed by crossing UAS-nos-tub3UTR31.1 (a viable line on the
second chromosome) or UAS-nos-tub3UTR41.1 (on the third chromo-
some) with drivers.
Analysis of GluRIIB levels in larvae where Nos was overexpressed in a
GluRIIA mutant background was done by crossing GluRIIASP22/Cyo
Actin-GFP;MHC-GeneSwitch GAL4/TM3 Serrate Actin-GFP and GluR-
IIAAD9/Cyo Actin-GFP;UAS-nos-tub3UTR41.1/TM3 Serrate Actin-GFP.
The control larvae for this experiment were generated by crossing Glu-
RIIASP22/Cyo Actin-GFP andGluRIIAAD9/Cyo Actin-GFP. Early third in-
star non-GFP larvae were transferred to plates containing 50 g/ml
RU486 for 2 d. They were then dissected and processed for GluRIIB
immunohistochemistry.
Antibodies
Rat anti-Nos was obtained from P. Macdonald (University of Texas,
Austin, TX) and used at 1:300. To generate a polyclonal mouse Nos
antibody, wemadeNos protein in Escherichia coli according to a protocol
provided by R. Wharton (Duke University). It was injected into mice at
theCaltechMonoclonal Antibody Facility, and the antiserumwas used at
1:300. To show that the Nos antibodies recognize Nos protein in situ, we
stained larvae that ectopically expressed Nos from GAL4 drivers and
demonstrated that the antibodies stained the appropriate patterns.
The other primary antibodies used in this study are listed below. Anti-
Bruchpilot [Brp; nc82 (Development Studies Hybridoma Bank; DSHB)]
was used at 1:100; tetramethylrhodamine isothiocyanate-horseradish
peroxidase (HRP; Jackson ImmunoResearch Laboratories) was used at
1:50; rabbit anti-Dlg (from P. Bryant, University of California, Irvine,
CA) was used at 1:1000; mouse anti-Dlg (DSHB) was used at 1:100;
mouse anti-GluRIIA (8B4D2; DSHB) and rabbit anti-GluRIIB (from A.
DiAntonio, Washington University) antibodies were used at 1:25 and
1:2000, respectively (Marrus et al., 2004); mouse anti-Synapsin (3C11;
DSHB) was used at 1:10; and rabbit anti-Drosophila p21-activated kinase
(fromN.Harden,University of Toronto, Toronto,Ontario, Canada)was
used at 1:2000. Secondary antibodies (Invitrogen) were used at 1:200.
Alexa-Fluor 488 anti-mouse and anti-rabbit antibodies were preab-
sorbed with wild-type embryos and used at 1:500 for Nos antibody
staining.
Immunocytochemistry/immunofluorescence
Third instar larvae were dissected, stained, and processed as described
previously (Menon et al., 2004). Briefly, dissected larvae were either fixed
in 4% paraformaldehyde for 30 min or in Bouin’s fix (Sigma) for 1–5
min. Ventral nerve cords (VNCs) were fixed at 4°C for 1 h in 4% para-
formaldehyde. Fixed larval fillets were incubated with primary and sec-
ondary antibodies and imaged on a Zeiss LSM510 confocal microscope.
All figures shown aremaximum intensity projections of confocal z-series
stacks unless stated otherwise. Images were combined using Adobe Pho-
toshop. Bouton number was quantitated from preparations that were
stained with either synapsin or Dlg and anti-HRP antibodies. Maximum
intensity projections of confocal z-series stacks were analyzed with Im-
ageJ software (National Institutes of Health), and those boutons that
showed synapsin labeling with an outline of HRP around the bouton
were counted. Muscle sizes were measured from wild-type and mutant
larvae, and these showed no significant differences.
For quantitation of GluRIIA and GluRIIB puncta at boutons, larval
preparations were either fixed in Bouin’s or in cold methanol for 5 min
(for GluRIIA antibody) or in Bouin’s for 1 min (for GluRIIB antibody)
(Schmid and Sigrist, 2008). Samples were stained either with GluRIIA
and anti-HRP antibodies or with GluRIIB and Dlg antibodies. Control
and experimental samples were processed together in the same tube and
imaged at the same settings on the Zeiss confocal microscope. Z-series
stacks were analyzed for intensity measurements using ImageJ software.
Confocal stacks were projected by summing all the slices and measuring
intensities in both channels at each bouton. For the analysis, three to five
terminal boutons from each branch of the muscle 4 NMJ from hemiseg-
ments A2 and A3 were quantitated. The background in each channel was
determined outside of the NMJ close to the bouton, and that value was
subtracted from the mean gray value at the bouton. The GluRIIA and
GluRIIB intensity values at each bouton were then normalized withHRP
or Dlg intensity measurements.
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Electrophysiology
For all genotypes, third instar larvaewere picked from thewalls of the vial
and dissected in Ca2-free HL-3 saline solution. Filleted larvae were
washed in solution containing Ca2 before recording. Recording elec-
trodes were heat-pulled glass capillaries with resistances between 15 and
40 M, filled with 3 M KCl. Miniature excitatory junctional potentials
(mEJPs) and evoked EJPs were recorded in the bridge mode using an
Axoclamp-2B amplifier and BrownLee preamplifier. The low-pass filter
was set at 1 kHz on the preamplifier. Recordings were performed on
muscle 6 in abdominal segments 2 and 3. Only those muscles with a
resting membrane potential 60 mV throughout the recording were
considered. Spontaneous events were recorded in current clamp for 3
min, and thesemEJP traces were analyzed by hand using theminianalysis
program Synaptosoft (by J. Lee; Synaptosoft). mEJP amplitudes and de-
cay times were measured with Synaptosoft. To determine whether the
faster decay rate seen in nos mutants was an effect of the events them-
selves being smaller, we separated mEJP events from both mutant
(nosRD/Df(3R)Exel6183) and wild type (w1118) into three groups: mEJP
amplitude 0.5 mV, mEJP amplitude 0.5–1 mV, and mEJP amplitude
1.5–2mV.We found that the difference in decay times betweenwild-type
and nosmutant values was similar for all three groups, indicating that the
faster decay rate observed in nos mutants was independent of the mEJP
amplitude. The decay time distribution was determined using the Syn-
aptosoft program. The first 50 mEJP events from each trace were binned
into 5ms decay timewith bins ranging from10 to25ms. Traces from
five animals with a total of 250 events were analyzed for each genotype.
For evoked recordings, suction electrodes were fire-polished down to 7
m tip size and filled with recording solution containing Ca2. Motor-
axons were stimulated with 4 A current at a frequency of 0.2 Hz, and
evoked EJPs were recorded from muscle 6 abdominal segment 2. The
average EJP amplitude was calculated from 10 sequential EJPs from each
animal. Student’s t test was used to determine significance.
RNA binding assays
Plasmid construction. Plasmids used for synthesis ofGluRIIA (wild-type),
hb, and nos RNA probes were generated by inserting annealed oligos
(with blunt ends) into the SmaI site of the pBluescript derivative pBS-
SKKP (Kalifa et al., 2006). Sense strand sequences are as follows:
GluRIIA, 5GATCGGTGTCCACATTGTATATTGTGAGCTATATT-
TGTAGAATTATTTT3; hb, NRE 5GATCTATTATTTTGTTGTCGA-
AAATTGTACATAAGCCT; hb NRE, 5GATCACTATCATAAAG-
ACTAGTCTGGAGAAACATT3; nos (wild type), 5GATCCACTT-
TGAATTTCGAACTGTCAATCGTATCATTAGAATTTAATCTT3. The
GluRIIA GUUA and nos M1, M2, and M3 mutant plasmids are based on
GluRIIAandnoswild typebut contain the sequencechanges shown inFigure
10A. For theGluRIIAM2plasmid, annealed oligos (5GATCCCGGTGTC-
CACATTGTATCTGAGACGCTATATTTGTAGAATTATTTTA3 and
5CTAGTAAAATAATTCTACAAATATAGCGTCTCAGATACAATGTG-
GACACCGG3) were cloned between the BamHI and SpeI sites of pBS-
SKKP. Plasmids used to synthesize nos 3UTRprobes forUV-crosslinking
have been described previously (Gavis et al., 1996a; Bergsten et al., 2001).
Purification of Pum RNA-binding domain. His-tagged Pum RNA-
binding domain (PumRBD) was expressed in E. coli BL21(DE3)pLysE at
29°C. The cell pellet was resuspended in lysis buffer (50mMTris-HCl, pH
8.0, 100 mM NaCl, 5 mM EDTA) containing 0.5% Triton X-100, 0.1 mM
PMSF, and 1mMDTT and sonicated four times for 1min. The lysate was
supplemented to 10mMMgSO4, and DNase (to 10g/ml) and lysozyme
(to 0.1 mg/ml) were added, followed by incubated at room temperature
for 20 min. The lysate was cleared by centrifugation for 10 min at 5000
rpm. The supernatant was passed twice over a Ni-NTA agarose (Qiagen)
column equilibrated with lysis buffer. After washing with 40 mM imida-
zole/50 mM Tris-HCl, pH 8.0, bound protein was eluted with 400 mM
imidazole/50 mM Tris-HCl, pH 8.0. Pooled eluate fractions were passed
over a PD10 column equilibrated to 50 mM Tris-HCl, pH 7.5/200 mM
KCl/1mMDTT/1mM EDTA/10% glycerol. Purified protein was concen-
trated to 1 mg/ml by centrifugal filtration (Centricon), aliquoted, and
stored at80°C.
In vitro binding assays. Linearized template DNAwas transcribed with
32P-dUTP as described previously (Bergsten et al., 2001). Before use,
32P-labeled probes were denatured by heating at 65°C for 5 min and
placed on ice. Gel mobility shift assays were performed as described
previously (Zamore et al., 1997), with the omission of Tween 20 from the
buffer. Competition assays were performed in an identical manner with
the addition of cold competitor RNA as indicated in the figure legend.
UV-crosslinking assays were performed as described previously (Berg-
sten et al., 2001) using the same binding buffer as for gel mobility shift
assays.
Results
Nos is localized to larval NMJs
To determine whether the distribution of zygotically expressed
Nos protein is similar to that of Pum, we localized Nos by immu-
nofluorescence using two antibodies generated by different
groups in different species. Both were shown to recognize ectopi-
cally expressedNos protein in situ (seeMaterials andMethods for
details). We focused on sites where Pum is expressed in third
instar larvae, including the NMJ, muscles, and VNC. All images
shown here are of NMJs in abdominal segments A2 or A3, visu-
alized by confocal microscopy.
At the NMJ, we found that Nos colocalized with the neuronal
marker recognized by anti-HRP antibody. Type 1b (big; arrow)
and type 1s (small; arrowhead) NMJ boutons are both glutama-
tergic and are from different neurons (Fig. 1A1). Nos was ob-
served at both types of boutons, using either antibody for staining
(Fig. 1A,B). Examination of a single confocal slice of an NMJ
(Fig. 1G) shows thatNos labeling is primarily confinedwithin the
bouton boundaries outlined by the neuronal marker. As de-
scribed below, our RNAi results show that most of the Nos at the
NMJ is postsynaptic, because it derives from expression in mus-
cles. This suggests that Nos is localized to the postsynaptic sub-
synaptic reticulum (SSR) immediately under and around the
bouton, so that a border between anti-HRP and Nos cannot be
distinguished by confocal microscopy. Nos was also observed in
neuronal cell bodies in the VNC (Fig. 1D). The outlines of anti-
HRP-labeled cell bodies coincide with Nos staining, indicating
that Nos is present in neuronal soma. Nos is absent from axons,
which are brightly labeled by anti-HRP.
For comparison, we have included some of our earlier data
showing Pum localization at theNMJ (Fig. 1C). Pum staining has
a more “postsynaptic” appearance than Nos staining at the NMJ,
because Pum colocalizes with the SSR marker Dlg. We also
showed that Pum staining forms rings around the presynaptic
marker Synaptotagmin (Menon et al., 2004).
Because proteins reactive with anti-Nos antibodies continue
to be expressed in strong nos mutants (Verrotti and Wharton,
2000), we could not use reduced staining of mutants to demon-
strate thatNos localization to theNMJ is authentic. Therefore, we
analyzed larvae in which Nos expression was knocked down us-
ing RNAi. We generated transgenic flies expressing a hairpin nos
RNAi under control of the yeast upstream activating sequence
(UAS), which binds to the GAL4 transcription factor. Nos
double-stranded RNA is expressed only when a GAL4 source is
provided by crossing a Nos RNAi line to a GAL4 “driver” line
(Brand and Perrimon, 1993). To examine protein expression, we
crossed a strongmuscle driver, C57-GAL4, toNosRNAi lines and
to wild-type control flies and analyzed larvae from these crosses
by staining with Nos antibody. Nos staining at the NMJ was
markedly decreased in muscle Nos RNAi larvae (Fig. 1, compare
E1, F1), whereas anti-HRP staining (Fig. 1E2,F2) was unchanged.
Similar results were obtained for other NMJs (data not shown).
These results show that most of the Nos protein that is localized
to theNMJderives fromexpression in postsynapticmuscle fibers.
To analyze neuronal Nos expression, we crossed a Nos RNAi
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line to the pan-neuronal driverC155 (Elav)-GAL4 (supplemental
Fig. S1, available at www.jneurosci.org as supplemental mate-
rial). Well defined outlines of neuronal cell bodies labeled with
Nos antibody in the control larval CNS (Fig. 1D) were absent in
animals in which neuronal Nos was knocked down (supplemen-
tal Fig. S1, available at www.jneurosci.org as supplemental mate-
rial). Although staining of cell bodies was reduced, staining of
NMJs in neuronal RNAi larvaewas unaffected (supplemental Fig.
S2, available at www.jneurosci.org as supplemental material).
Neuronal Nos regulates bouton number and NMJ branching
For analyzing nos mutant phenotypes, we used transheterozy-
gotes of the strong nos alleles nosRC and nosRD in combination
with two deficiency (Df) mutations, Df(3R)Exel6183 and
Df(3R)Dl-FX1, which delete the nos gene. nosRC is a point muta-
tion in the splice donor of intron 1, and nosRD (Cys354Tyr) is a
missense mutation in the conserved C-terminal domain (Curtis
et al., 1997). nosRD encodes an unstable protein, whereas nosRC
mutant expresses low levels of full-length protein (Verrotti and
Wharton, 2000). Both nosRC and nosRD produce strong maternal
phenotypes affecting abdominal segmentation and germ cell mi-
gration. Zygotic nosRCmutants have defects in dendritic branch-
ing in the PNS (Ye et al., 2004). In our hands, neither allelic
combination resulted in a reduction in Nos staining in the larval
CNS or at theNMJ. In fact, Nos protein at theNMJwas increased
in these transheterozygotes (see below).
Figure 1. Nos is localized to the larval NMJ. A–C, Muscle 4 NMJs of A2 segments stainedwithmouse Nos antibody (A1, green in A), rat Nos antibody (B1, green inB), and Pum antibody (C1, red
in C). Double labelingwith anti-HRP in red (A,B) andwith anti-Dlg in green (C) is shown. Type 1bboutons are indicated by arrows (A1,B1), and type 1s boutons are indicated by the arrowhead (A1).
D, Larval VNC staining with mouse Nos antibody (D1, green in D) and anti-HRP (red in D). The asterisk indicates axons, and the bracket shows medial neurons that stain with Nos antibody and
anti-HRP. E, F, Muscle 6/7 NMJs of A3 segments stainedwithmouse Nos antibody (E1, F1) and anti-HRP (E2, F2). E and F aremerged images. Themuscle control NMJ (E) is from C57-GAL4 crossed
tow1118. The muscle Nos RNAi NMJ (F ) is from C57-GAL4 crossed to Nos RNAi. Note the reduction in staining in F1 compared with E1; the anti-HRP signal is the same in E2 and F2. All panels are
confocal z-series projections, except forD1,D,G1, andG, which are single sections.G, A cross section of a 6/7 A2 NMJ labeledwithmouse Nos antibody (G1, green inG) and anti-HRP (G2, red inG).
Scale bars: A, D, E, 10m; C, 5m.
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To study how loss of Nos function affects NMJ structure, we
examined third instar NMJ architecture and boutonmorphology
in nos mutants. It is apparent that there are more boutons at
NMJs in mutants compared with those in control larvae (Fig.
2A–C). Muscle sizes in mutants were not significantly different
from controls. Quantitation of bouton number in the three ge-
notypes showed that the strongest effect is observed in nosRC/Df
(3R)Dl-FX1, with a 1.7-fold increase in bouton number relative
to control larvae (wild-type wcs: 114.9 4.9 boutons/NMJ, n	
18; nosRD/Df (3R)Exel6183: 162.6 9, n	 16; nosRC/Df (3R)Dl-
FX1: 195.3  15.9, n 	 15) (Fig. 2F). These phenotypes are
different from those we previously defined for pum mutants,
which are described in detail in published work (Menon et al.,
2004). Boutons in pum mutants are irregularly shaped, fewer in
number, and larger in size than those at control NMJs (Fig.
2D,E). In contrast, boutons on all muscles in nos mutants have
relatively normal sizes and shapes.
We then asked whether the phenotypes seen in nos mutants
were caused by the loss of Nos function in the neurons, in the
muscles, or both. To address this, we crossed our Nos RNAi lines
to the pan-neuronal driver C155-GAL4, resulting in a reduction
in Nos protein only in neurons. Figure 3 showsmuscle 4 NMJs of
control larvae [C155-GAL4 crossed to w1118 (A)] and neuronal
Nos RNAi larvae [C155-GAL4 crossed to Nos RNAi (B)] (two
independent RNAi insertions were tested, on the second and
third chromosomes, and they produced similar phenotypes).
Quantitation of bouton numbers on muscle 6/7 of F1 larvae
showed that RNAi knockdown of Nos in neurons resulted in a
1.6-fold increase in the number of boutons compared with neu-
ronal control NMJs (C155-GAL4 crossed to wild type; control:
124.1  4.8, n 	 11; neuronal Nos RNAi: 202.3  5.7, n 	 12;
Student’s t test, p 0.0001) (Fig. 3G). Bouton numbers were also
increased by 1.3-fold, however, at NMJs of muscle Nos RNAi
larvae (24B-GAL4 crossed to Nos RNAi) compared with control
animals (control: 137.3 7.7, n	 15;muscleNos RNAi: 183.8
9.8, n	 12; Student’s t test, p 0.001) (Fig. 3D,E,G). 24B-GAL4
is another early muscle-specific GAL4 driver, similar in strength
to C57-GAL4. These data suggest that the increase in bouton
number observed in nosmutants is a consequence of reduction in
both presynaptic and postsynaptic Nos functions.
We also examined the effects of overexpressing Nos in neu-
rons or inmuscles on bouton number. This was done by crossing
a motor neuron-specific driver, OK6-GAL4, or a muscle driver,
24B-GAL4, to a transgenic line bearing a construct in which the
nos 3UTR was replaced with the tubulin (tub) 3UTR (nos-
tub3UTR) (Gavis et al., 1996b). This transgene lacks all nos
3UTR regulatory sequences and therefore expresses Nos at high
levels when crossed to drivers.
Neuronal overexpression of Nos produced boutons with ir-
regular rounded shapes and caused a slight increase in bouton
numbers (neuronal control: 184  9.3, n 	 13; neuronal Nos
overexpression: 222 12.4, n	 14) (Fig. 3C). In contrast, neu-
ronal overexpression of Pum generates abnormal NMJs com-
posed of numerous tiny boutons compacted into a small area
(Menon et al., 2004). Muscle overexpression of Nos produced
dramatic changes in the morphology of NMJs (Fig. 3F). It was
not possible to count boutons in these NMJs because of their
abnormal clustering.
Perturbation of Nos expression in neurons affects active zone
numbers in type 1s boutons
A closer examination of one of the two types of glutamatergic
boutons, type 1s, in neuronal Nos overexpression and RNAi lar-
vae showed interesting alterations in the distribution of active
zones (AZs). AZs were visualized with the Brp marker (Kittel et
al., 2006; Wagh et al., 2006) (Fig. 3H). The numbers of Brp
puncta in type 1s boutons (recognized by weak staining for the
SSR marker Dlg) are reduced in neuronal Nos overexpression
Figure2. NosmutantNMJs have an increasednumber of synaptic boutons.A–C,Muscle 6/7NMJs of A2 segments labeledwith synapsin (red) and anti-HRP (green) antibodies inwild-type (WCS)
and twonosmutant transheterozygotes,nosRD/Df(3R)Exel6183 andnosRC/Df(3R)Dl-FX1.D,E,Muscle 4NMJs of A3 segments labeledwith anti-HRP antibody inwild type (w1118) andpumET9/pumET7.
Note the large boutons and the fused bouton phenotype in E. F, A graph of the total bouton number at 6/7 A2 NMJs for three genotypes:WCS, nosRD/Df(3R)Exel6183, and nosRC/Df(3R)Dl-FX1. The
differences betweenWCS and nosmutants are highly significant ( p 0.005 and p 0.0001, Student’s t test). Scale bars: A, D, 10m.
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larvae (Fig. 3J). The total number of AZs (Brp puncta) in the
entire type 1s arbor of muscle 4 NMJs was decreased by twofold
compared with controls (control, 168.2  19.3; neuronal Nos
overexpression larvae, 82.6  11.6) (Fig. 3 J,K). We also scored
the number of Brp-marked AZs per type 1s bouton and found
that neuronal Nos overexpression larvae had a threefold increase
in the fraction of type 1s boutons that had only one AZ (11.7
2.4 boutons with one AZ in control muscle 4 NMJs; 35.7  2.2
boutons with one AZ in neuronal Nos overexpression). The
number of Brp puncta in type 1b boutons of neuronal Nos over-
expression larvae were not significantly different from controls
(data not shown).
Having noted the decrease in Brp-marked AZs conferred by
neuronal overexpression of Nos, we wondered whether reduc-
tion of Nos in neurons would also produce an AZ phenotype.We
found that knockdown of neuronal Nos with RNAi resulted in
the opposite effect, producing a 1.7-fold increase in AZs (Brp
puncta) in type 1s boutons relative to controls (neuronal Nos
RNAi, 282.5 15.7) (Fig. 3 I,K). An increase was also seen in nos
mutants (wild type, 138.6 13.1; nosRC/Df(3R)Dl-FX1, 215.1
25.9) (Fig. 3K).
Postsynaptic Nos regulates GluRIIA and GluRIIB, acting in
opposition to Pum
Wenext analyzed the functions ofNos on the postsynaptic side of
the NMJ. GluRIIA is dramatically upregulated in pum mutants
Figure 3. Perturbation of Nos alters bouton and AZ numbers. A–F, Muscle 4 NMJs of A2 segments labeled with anti-HRP (red) antibody for neuronal (A–C) andmuscle (D–F ) Nos RNAi and Nos
overexpression.A–C, Neuronal control (C155-GAL4 crossed tow1118;A), C155-GAL4 crossed to Nos RNAi (B), andOK6-GAL4 crossed to a UAS-Nanos line (C, Nos OE). Neuronal drivers C155-GAL4 and
OK6-GAL4 produced similar phenotypes when used to overexpress Nos. The arrow in C shows an irregularly shaped type 1b bouton. D–F, Muscle control (24B-GAL4 crossed to w1118; D), muscle
knockdown of Nos (24B-GAL4 crossed to a Nos RNAi line; E), andmuscle overexpression of Nos (Nos OE; 24B-GAL4 crossed to a UAS-Nanos line; F ). Note the abnormal structure of the entiremuscle
4 NMJ when Nos is overexpressed inmuscles (F, arrow). G, A graph of the total bouton number at muscle 6/7 clefts in neuronal control (n	 11), neuronal Nos RNAi (n	 12), muscle control (n	
15), andmuscle Nos RNAi (n	 12) larvae. The difference in bouton number between NMJs of neuronal control and neuronal Nos RNAi larvae and betweenmuscle control andmuscle Nos RNAi are
highly significant (Student’s t test; p 0.0001 and p 0.001, respectively).H–J, Type 1s boutons of muscle 4 NMJs in A2 segments labeled for the AZmarker Brp (red) and Dlg (green) are shown
for neuronal control (H ), neuronal Nos RNAi (I ), and neuronal Nos overexpression (J ). K, The total number of AZs in type 1s boutons of muscle 4 NMJs in A2 segments were quantitated in five
genotypes: neuronal control (n	 9), neuronal Nos overexpression (Nos OE; n	 7), neuronal Nos RNAi (n	 8), wild type (w1118; n	 5), and nosRC/Df(3R)Dl-FX1 (n	 7). The differences between
control, neuronal OE (Student’s t test, p 0.005), and neuronal RNAi ( p 0.0005) lines are highly significant. Scale bars: A, I, 5m.
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(Menon et al., 2004) (see Fig. 8). If Nos acts as a Pum corepressor
in regulating GluRIIA translation, we would expect to see a sim-
ilar increase inGluRIIAwhen postsynapticNos is knocked down.
In these experiments, we examined larvae in which Nos was de-
pleted frommuscles using RNAi or was overexpressed inmuscles
using the nos-tub3UTR transgene. For these muscle RNAi and
overexpression experiments, we used the myosin heavy chain
(MHC)-GAL4 driver, which is switched on in somatic muscles in
first instar larvae and remains active throughout larval life. This
was because Nos overexpression from strong, early muscle driv-
ers such as 24B- and C57-GAL4 alters NMJ morphology (Fig.
3F), whereas MHC-GAL4-driven expression does not. We
crossed MHC-GAL4 with control or Nos RNAi lines and ana-
lyzed F1 larvae from these crosses by anti-GluRIIA immunoflu-
orescence. Surprisingly, we saw a decrease in GluRIIA immuno-
reactivity relative to control larvae [Fig. 4, compareA1, B1 (green
in A and B)] when Nos was knocked down in the muscles with
RNAi. Conversely, Nos overexpression resulted in an increase in
GluRIIA levels [Fig. 4, compare C1, D1 (green in C and D)].
Perturbation ofNos expression had no effect on expression of the
anti-HRP marker used for double staining of the NMJs.
To quantitatively assess these effects, wemeasured the average
fluorescence intensity of GluRIIA at distal boutons, normalizing
these values to the intensity of the marker used for double stain-
ing (see Materials and Methods for details). This measurement
reflects both the number of GluRIIA puncta and their individual
intensities. Larvae used for quantitation were processed and im-
aged together under the same experimental conditions. We
found that RNAi knockdown decreases GluRIIA by fourfold,
whereas overexpression increases it by twofold. The values for
MHC-GAL4/Nos RNAi (0.11 0.03; n	 16) and MHC-GAL4/
Nos OE (0.98  0.11; n 	 16) were significantly different from
control MHC-GAL4/ (0.47  0.08; n 	 35) (Student’s t test,
p 0.0005 and p 0.005, respectively).
The ionotropic muscle glutamate receptor inDrosophila con-
sists of five known subunits: GluRIIA, GluRIIB, GluRIIC, Glu-
RIID, and GluRIIE (Marrus et al., 2004; Qin et al., 2005). A func-
tional receptor is composed of either IIA or IIB in addition to
Figure 4. Knockdown of postsynaptic Nos causes downregulation of GluRIIA, and Nos overexpression upregulates GluRIIA. A–D, Muscle 4 NMJs in A2 segments labeled with anti-GluRIIA and
anti-HRP. A, C, Control NMJs (MHC-GAL4 crossed to w1118). B, An NMJ from Nos RNAi crossed to MHC-GAL4. D, An NMJ from UAS-Nos crossed to MHC-GAL4 (Nanos OE). A, B, GluRIIA levels are
decreased when Nos is knocked down in muscles (compare A1, B1; green in A and B). Anti-HRP (neuronal marker) levels are similar in both control and Nos RNAi NMJs (A2, B2; red in A and B). C,
D, GluRIIA levels are increased when Nos is overexpressed in muscles (compare C1, D1; green in C and D). Anti-HRP labeling is similar in control and overexpression larvae (C2, D2; red in C and D).
Two control NMJs are shown in this figure because the larvae for the RNAi or the overexpression crosseswere processed and imaged at the same time alongwith their corresponding control animals
in the same tube. Scale bar: A, 5m. E, Quantitation of GluRIIA at muscle 4 NMJs in control, Nos RNAi, and Nos overexpression (Nos OE). GluRIIA levels in distal boutons were quantitated and
normalized against anti-HRP. This is represented asmean gray value of GluRIIA/HRP per hemisegment (seeMaterials andMethods). The values for MHC-GAL4/Nos RNAi (0.11 0.03, n	 16) and
MHC-GAL4/Nos OE (0.98 0.11, n	 16) were significantly different from control MHC-GAL4/ (0.47 0.08, n	 35) (Student’s t test; p 0.005 and p 0.0005, respectively).
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subunits IIC, IID and IIE, which are invariant. Channel proper-
ties differ between receptors with a IIA subunit and those with a
IIB subunit (Petersen et al., 1997; DiAntonio et al., 1999) (see
below for further discussion). The decrease in GluRIIA caused by
Nos knockdown motivated us to examine GluRIIB levels as well.
When Nos was knocked down in muscles, the amounts of
GluRIIB at NMJ boutons [Fig. 5, compareA1, B1 (green inA and
B)]were increased comparedwith control larvae.Quantitation of
GluRIIB at muscle 4 NMJs in control and Nos RNAi showed that
RNAi knockdown produced a threefold increase in GluRIIB.
GluRIIB labeling from distal boutons was quantitated and nor-
malized against Dlg. This is represented as themean gray value of
GluRIIB/Dlg per hemisegment (seeMaterials andMethods). The
values for MHC-GAL4/Nos RNAi (0.41  0.1; n 	 18) were
significantly different from control MHC-GAL4/ (0.14 0.08;
n	 18) (Student’s t test, p 0.02).
GluRIIA and GluRIIB receptors fluctuate in opposition to
each other, such that a decrease in synaptic GluRIIA receptors at
the NMJ is coupled to an increase in GluRIIB receptors, and vice
versa (Petersen et al., 1997; DiAntonio et al., 1999; Sigrist et al.,
2002). This suggests that the observed increase in GluRIIB inNos
RNAi knockdown larvae could be an indirect consequence of the
reduction in GluRIIA that occurs in these larvae. To address this
question, we examined GluRIIB in larvae that are heterozygous
for a GluRIIA null mutation over a deficiency that removes both
GluRIIA and GluRIIB (these genes are closely linked). Because
GluRIIB should already be upregulated in these larvae, we did not
examine the effect of Nos RNAi on its levels, but rather asked
whether Nos overexpression could reduce GluRIIB. This is a dif-
ficult experiment because of the low signal-to-noise ratio often
observed with the anti-GluRIIB antibody. However, we were able
to show that Nos overexpression reduced GluRIIB levels by
threefold (Student’s t test, p  0.005) (Fig. 5, compare C1, D1
(green in C and D)]. These data indicate that the regulation of
GluRIIB by Nos is at least partially independent of GluRIIA.
Electrophysiological nanos phenotypes are consistent with an
increase in GluRIIB-dominated synapses
To evaluate the functional relevance of the control of GluRIIB by
Nos, we recorded from the NMJs of nos mutants (Fig. 6). nos
mutants had a 40% decrease in mEJP (mini) amplitude com-
pared with wild-type controls (control: 1.01 0.01 mV, n	 19;
nosRD/Df (3R)Exel 6183, 0.61 0.003mV,n	 26; Student’s t test,
p 0.0001) (Fig. 6A). The decrease in mini amplitude was par-
tially rescued by muscle expression of Nos in the mutant back-
ground (muscle rescue: 0.82 0.06 mV, n	 14). The difference
between mutant and muscle rescue values is highly significant
(Student’s t test, p 0.0001). We also confirmed that Nos in the
muscle is primarily responsible for the decrease in mini ampli-
tude by knocking downNos in larvalmuscles with RNAi. The nos
mutant phenotype was recapitulated in muscle Nos RNAi larvae,
as mini amplitudes were decreased by 40% compared with con-
trol larvae (control: 0.82 0.06 mV, n	 15; muscle Nos RNAi:
0.50 0.003 mV, n	 15; Student’s t test, p 0.0001) (Fig. 6A).
Representative mEJP traces for all genotypes are shown in Fig.
6E. We also examined mini amplitudes in neuronal Nos RNAi
Figure 5. Knockdown of Nos in muscles upregulates GluRIIB, and Nos overexpression in muscles in a GluRIIAmutant downregulates GluRIIB. A, B, Muscle 4 NMJs in A2 segments labeled with
anti-GluRIIB and anti-Dlg. MHC-GAL4/ (A) is a control NMJ (MHC-GAL4 muscle driver crossed tow1118), and MHC-GAL4/Nos RNAi (B) is a Nos RNAi line crossed to MHC-GAL4. GluRIIB levels are
increased when Nos is knocked down in muscles (compare A1, B1; green in A and B). Dlg labeling is the same in control and Nos RNAi NMJs (A2, B2; red in A and B). GluRIIB labeling from distal
boutons at muscle 4 NMJs was quantitated (see Materials and Methods), and these values were normalized against Dlg intensity. The mean gray value of GluRIIB/Dlg per hemisegment for
MHC-GAL4/Nos RNAiwas 0.41 0.1 (n	 18), significantly different from controlMHC-GAL4/ (0.14 0.08; n	 18; Student’s t test, p 0.02). C,D,Muscle 4NMJs in A2 segments labeledwith
anti-GluRIIB and anti-HRP. C, Control NMJ, AD9/SP22, is a transheterozygote of a GluRIIA null mutant GluRIIAAD9 over a deficiency GluRIIASP22 that removes both GluRIIA and GluRIIB. D, AD9/SP22;
GSmus/NosOE is an AD9/SP22 animal in which Nos is overexpressed from theMHC-GeneSwitch-GAL4 driver. Note that GluRIIB levels are decreased at the boutons of the NMJ in animals where Nos
is overexpressed in a GluRIIA mutant (compare D1, C1; green in C and D). The magnitude of the decrease is approximately threefold (see Results). HRP labeling is the same in both control and
experimental NMJs (C2, D2; red in C and D). Scale bars: A, C, 5m.
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larvae. These values were not significantly different from wild
type (control: 0.8 0.09 mV, n	 9; neuronal Nos RNAi: 0.79
0.06, n	 8).
Wemeasured evoked transmitter release from control and three
nos transheterozygous genotypes. Evoked excitatory junctional po-
tential (eEJP) amplitudes were similar between control andmutant
animals (Fig. 6C). Traces showing evoked responses from these ge-
notypes are shown in Figure 6F. Restingmembrane potentials were
approximately the same for all genotypes tested (Fig. 6D). The fre-
quencies of spontaneous release events were not significantly differ-
ent between wild type andmutants (data not shown).
The decrease in mini amplitude seen in nosmutant and mus-
cle RNAi larvae is consistent with the expected effect of derepres-
sion of GluRIIB by loss of Nos, because GluRIIB overexpression
was previously shown to result in a decrease in the amplitude of
spontaneous release events. It was also demonstrated that minis
fromGluRIIB-dominated synapses have a faster decay time com-
pared with GluRIIA-dominated synapses (DiAntonio et al.,
1999). We thus extended our analysis to look at the decay time of
spontaneous release events in the genotypes described above (Fig.
6B) (see Materials and Methods). We found that mEJPs in nos
mutants had faster decay times compared with control larvae
(control: 24.32 1.33 ms, n	 9; nosRD/Df(3R)Exel6183: 11.6
0.34 ms, n 	 15; Student’s t test p  0.0001) (example traces of
one spontaneous release event with the same amplitude from
both genotypes are shown in Fig. 6E). The decrease in decay time
was rescued by expressing Nos in the muscle in the mutant back-
ground (muscle rescue: 23.2 1.07ms, n	 14). Knocking down
Nos in muscles with RNAi produced a similar decrease in the
decay time (control: 22.4 1.5ms, n	 15; Nos RNAi: 14.3 1.5
ms, n	 15; Student’s t test, p 0.001). A histogram showing the
distributions of decay times in the various genotypes is shown in
Figure 6G. The mutant and muscle Nos RNAi animals have a
much larger fraction of events with fast decay times compared
with controls and muscle rescue animals.
The changes in the time constants of mEJP decay relative to
controls seen in nosmutant andNos RNAi larvae are in the range
of 1.5- to 2-fold. This ratio is comparable to that reported by
DiAntonio et al. (1999) for GluRIIA versus GluRIIB-dominated
synapses. In summary, the electrophysiological changes we ob-
serve when postsynaptic Nos is reduced are consistent with the
idea that GluRIIB synapses become the dominant type under
these conditions.
Figure 6. The amplitudes of mEJP events are decreased in nanosmutants. For electrophysiological analysis of the muscle 6/7 NMJ, recordings were done frommuscle 6 in A2 and A3 segments.
The number of animals that were analyzed for each genotype is indicated at the bottom of the bars. A, A graph of the amplitudes of mEJPs in various genotypes. Controls were two wild-type
genotypes,w1118 (n	10) andWCS (n	9), andadriver crossed tow1118 control (n	15) for theRNAi animals. Amplitudeswere reduced inmutants andmuscleRNAi larvae.B, A graphof thedecay
time (time constant) of mEJPs in the same genotypes. Decay was faster in mutants and muscle RNAi larvae. C, A graph of eEJPs in various genotypes. There were no significant differences among
genotypes.D, A graph of restingmembrane potential in the five genotypes in A and B. All the animals that were used for recordings had resting potentials that weremore negative than60mV.
This indicates that all preparations were equally healthy. E, Three representative traces of spontaneous events for the five genotypes in A and B. To show the faster decay in the mutant compared
with the control, one spontaneous event from a control (w1118, gray) trace and one from a nanos transheterozygote [nosRD/Df(3R)Exel6183, black] trace that had the same mEJP amplitudes are
shown.F,RepresentativetracesofevokedresponsesfromthethreegenotypesinC.Eachtraceisanaverageof10sequentialeEJPsfromoneanimal.G,AhistogramshowingthedistributionofdecaytimesofmEJP
events in thedifferent genotypes. The first 50mEJP events from traces of five animals (a total of 250 events per genotype)were analyzed andput in bins corresponding todecay times of10, 10–15, 15–20,
20–25, and25ms. Themutant andmuscleNos RNAi animals have amuch larger number of eventswith fast decay times comparedwith controls andmuscle rescue animals.
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Postsynaptic Nos is upregulated in pumiliomutants
GluRIIA is upregulated in pummutants (Menon et al., 2004) (see
Fig. 8), but also in muscle Nos overexpression larvae (Fig. 4). nos
mRNA is downregulated in neurons when the PumRBD is over-
expressed (Muraro et al., 2008). Binding of PUF-domain pro-
teins tomRNAs does not necessarily decrease their levels, but this
result does suggest that nos mRNA is affected by Pum. Also, nos
mRNAwas one of a large number ofmRNAs that were copurified
with an epitope-tagged PumRBD protein expressed in ovaries
(Gerber et al., 2006). Because of these findings, we wondered
whether Nos might be translationally repressed by Pum, so that
Nos overexpression could contribute indirectly to the upregula-
tion of GluRIIA observed in pummutants as a result of the neg-
ative effect of GluRIIB on GluRIIA.
To evaluate this idea, we examined the levels of Nos in pum
mutants and found that Nos staining was increased, as evaluated
with both antibodies (Fig. 7, compare A1, B1 and C1,D1). These
larvae were processed and imaged together under the same ex-
perimental conditions; they were imaged so that the Nos staining
in wild type is barely detectable, to clearly display the increase in
staining seen in pum mutants. Labeling with the anti-HRP
marker was the same in wild type and mutant. Muscle Nos was
also upregulated in larvae in which postsynaptic Pum was
knocked down using a Pum RNAi line (supplemental Fig. S3,
available at www.jneurosci.org as supplemental material). Nos
was not upregulated in the VNC of pummutants, suggesting that
Pum does not control Nos protein levels in most larval CNS
neurons (data not shown). We also examined Dlg in pum mu-
tants, because it was found to be downregulated by Pum overex-
pression in the mushroom body (Chen et al., 2008). Dlg staining
at the NMJ was not increased in pum mutants [Menon et al.
(2004), their Fig. 2].
Because Nos is a corepressor for Pum in most contexts, we
wondered whether Nos repression by Pum might require Nos
itself. We tested this idea by examining nosmutants, which con-
tinue to make inactive Nos proteins (Verrotti and Wharton,
2000), by staining with Nos antibodies. If Nos regulates its own
expression, then Nos-immunoreactive protein levels might in-
crease innosmutants. Confirming this prediction,Nos labeling at
the NMJ in a nos mutant (nosRC/Df(3R)Dl-FX1) was increased
compared with controls (Fig. 7, compare E1, F1). Three other
transheterozygous nos mutant combinations were tested and
produced the same result. In addition toNos staining at theNMJ,
muscle surface expression of Nos is increased in both pum and
nosmutants (Fig. 7, compare green signals inmerged panels).We
also examined eIF-4E staining in nos mutants and found that it
was unchanged (data not shown).
Pum binds selectively toGluRIIA mRNA
There are several possible models that could account for the in-
crease in GluRIIA seen in pum mutants (Fig. 8A,B). First, dere-
pression of synaptic eIF-4E (Menon et al., 2004) might cause an
increase in translation of GluRIIA mRNA, which is localized to
the synaptic region of the muscle fiber (Sigrist et al., 2000). Sec-
ond, derepression of Nos could indirectly affect GluRIIA by
downregulatingGluRIIB. Third, Pummight bind directly toGlu-
Figure 7. Nos protein expression at the NMJ is increased in pumilio and nanosmutants. Muscle 4 NMJs labeledwith rat Nos antibody (A,B, E, F ) ormouse Nos antibody (C,D) and double stained
with anti-HRP. NMJs are fromwild-type (w1118;A, C, E), pummutants ( pumET7/pumET9;B,D), and a nosmutant [nosRC/Df(3R)Dl-FX1; F].A–D, Both Nos antibodies reveal a large increase in staining
at the postsynaptic side of the NMJ and on themuscle surface in pummutants [compare A1, B1 (green in A and B for the rat Nos antibody); C2, D2 (green in C and D for the mouse Nos antibody)].
Segment A3 (A, B) and segment A2 (C, D) are shown. Scale bar: A, 10m. E, F, The levels of Nos-immunoreactive protein at the A3 NMJ and on themuscle surface are increased in this nosmutant
(compare E1, F1; green in E and F ), as well as in two other transheterozygous nos genotypes (data not shown). Anti-HRP labeling is similar in all genotypes. The different appearance of the NMJs
in B and D reflects the pum phenotype. Arrowheads indicate type 1b boutons, and N indicates a nucleus.
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RIIA mRNA to repress its translation. To
test the direct interaction model, we con-
ducted in vitro binding experiments with
the purified PumRBD. Pum binding sites
have previously been identified in a num-
ber of mRNAs. For hb, bicoid, CycB, eIF-
4E, para, and Dlg, it has been demon-
strated that Pum can regulate expression
of the encoded proteins in vivo (Wharton
and Struhl, 1991; Menon et al., 2004;
Kadyrova et al., 2007; Chen et al., 2008;
Muraro et al., 2008).
A four-nucleotide (nt) consensus mo-
tif, UGUA, is found in most Pum binding
sites, and mutation of this motif disrupts
Pum binding (Zamore et al., 1999). The
3UTR of the GluRIIA mRNA contains
two UGUA motifs separated by 16 nt.
Therefore, to test whether Pum can di-
rectly interact withGluRIIAmRNA,we fo-
cused on this region of the 3UTR. A 49 nt
RNA probe encompassing the two motifs
was synthesized and tested for Pum bind-
ing using electrophoretic mobility shift as-
says (EMSA). A recombinant protein en-
compassing the PumRBD bound to this
RNA probe, generating two complexes
with differentmobilities (Fig. 8C). The ap-
pearance of the upper (lower mobility)
complex (Fig. 8, label 2) at higher
PumRBD concentrations suggests that it
resulted from binding of two PumRBD
molecules to the GluRIIA probe. The in-
teraction of the PumRBD with GluRIIA
mRNA was specific, because binding
could be competed away by the addition of
excess unlabeled GluRIIA RNA but not by
an excess of an hb RNA fragment from which the NRE is deleted
(Fig. 8D, hb NRE). Interestingly, the wild-type hb NRE se-
quence competed less effectively for binding than the GluRIIA
sequence, suggesting that the GluRIIA 3UTR may have a higher
affinity for the PumRBD than does the hb NRE.
To determine whether the interaction of Pum with GluRIIA
sequences depends on the UGUA motifs, we generated mutant
probes in which both UGUA motifs were altered to GUUA (Fig.
9A), a mutation previously shown to abolish the binding of Pum
to the hb 3UTR (Wharton et al., 1998). The GUUA mutations
disrupted formation of the more slowly migrating complex (Fig.
9B, label 2) but had little effect on the more rapidly migrating
complex (Fig. 9B, label 1). These results suggest that the double
GUUA mutation prevents binding of one PumRBD molecule,
since it eliminates the band with two bound PumRBDs (band 2)
but preserves the band with one bound PumRBD (band 1). The
other PumRBD molecule, then, binds to a distinct sequence,
which we identified by making another mutation.
The Pum-related fem-3-binding factor (FBF) proteins from
Caenorhabditis elegans recognize a distinct motif that also con-
tains a core UGU triplet (Lamont et al., 2004; Bernstein et al.,
2005). The GluRIIA probe sequence contains a UUGUG motif
that fits the FBF binding consensus. Mutation of this sequence
(M2) in theGluRIIA probe also prevented formation of the com-
plex with two Pummolecules (band 2), but not the complex with
one molecule (band 1) (Fig. 9B). Thus, a GluRIIA probe with a
mutation in either the UGUA or M2 sites binds to one PumRBD
molecule, whereas a wild-type probe binds to two PumRBDs.
Together, these results are consistent with binding of Pum to two
different motifs within the GluRIIA 3UTR: a canonical UGUA
motif and an FBF site-like recognition motif.
Pum binds selectively to the nanos 3UTR
In pum mutants, the levels of eIF-4E, GluRIIA, and Nos are all
increased, and we have shown that Pum binds selectively to the
eIF-4E (Menon et al., 2004) and GluRIIA 3UTRs (Fig. 8). We
thuswonderedwhether thenos 3UTRmight also be a direct Pum
target. Sequences thatmediate localization and translational con-
trol of nosmRNA in the oocyte, embryo, and PNS reside within
the nos 3UTR (Gavis and Lehmann, 1992, 1994; Forrest et al.,
2004; Brechbiel andGavis, 2008). A singleUGUAmotif is present
in the nos 3UTR, in a region with no previously identified regu-
latory function. We surveyed fragments spanning the nos 3UTR
for Pum binding using a UV-crosslinking assay. Only one frag-
ment (nos 3UTR nucleotides 403–553) was bound by the
PumRBD (Fig. 9C). Notably, PumRBD did not crosslink to a
fragment containing the UGUAmotif (data not shown), indicat-
ing that Pum interacts with the nos 3UTR through one or more
alternative binding sites.
ClustalW alignment of sequences from the GluRIIA and nos
3UTR fragments bound by Pum identified a 31 nt region with
58% sequence identity (common nucleotides indicated in red in
Figure 8. Pumbinds selectively to the GluRIIA 3UTR.A,B, Upregulation of GluRIIA in pummutants (image fromMenon et al.,
2004). Muscle 12 NMJs are shown, labeledwith anti-GluRIIA (red) and anti-Synaptotagmin (Syt; green), which strongly labels 1b
boutons (arrows) and weakly labels 1s boutons (arrowheads). Note the dramatic increase in GluRIIA staining in the mutant,
especially around type 1s boutons. C, Gel mobility shift assay (EMSA) for interaction of PumRBDwith a 32P-labeled GluRIIA 3UTR
RNA probe. Binding reactions contained the same amount of RNA probe and either 0 () or an increasing concentration of
PumRBD protein (ramp above lanes). D, Binding of PumRBD to the 32P-labeled GluRIIA 3UTR RNA probe was challenged by an
increasing (300-, 500-, 1000-, and 5000-fold) molar excess of an unlabeled competitor GluRIIA 3UTR RNA, hb NRE RNA, or hb
NRE RNA. Binding reactions contained either no () or a constant amount of PumRBD. Complexes 1 and 2 and unbound probe
(p) are indicated. Note that the lanewith the highest amount ofhb competitor (right lane inmiddle panel) has probe and complex
bands of the same intensity as the second lane from the right in the left panel, which has a fivefold lower amount of GluRIIA
competitor. This shows that the GluRIIA sequence competes more effectively for binding than does the hb NRE.
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Fig. 9A). The PumRBD bound to a 50 nt probe encompassing the
nos sequence, as assayed by EMSA, suggesting that the conserved
nucleotides represent a Pum binding site. To test this hypothesis,
we generated three sets of mutations that alter conserved se-
quences within the nos 3UTR fragment (Fig. 9A) and assayed the
effect of these mutations on Pum binding. The nos M1 and M3
mutations had no significant effect on Pum binding relative to
the wild-type sequence (Fig. 9D). However, the ability of Pum to
interact with the nos sequence was diminished by the M2 muta-
tion. This decrease in binding is detected as a diminution in the
intensity of the complex bands, coupled to a failure of complex
formation to deplete the unbound probe [Fig. 9D, compare in-
tensity of the unbound bands (arrowheads) in the right two
nos-M2 lanes with the corresponding lanes for wild-type, M1,
and M3 mutants). The M2 mutation disrupts a UGU triplet that
corresponds to the FBF-like binding site in GluRIIA. These re-
sults indicate that Pum recognizes the nos 3UTR, as well as the
GluRIIA 3UTR, using a motif that differs from the UGUA con-
sensus. Remarkably, a 9 nt sequence spanningM2 is identical to a
sequence within the 51 nt minimal Pum-binding fragment of the
eIF-4E 3UTR (Menon et al., 2004). This suggests that M2-like
sequencesmay represent a new type of synaptic Pumbinding site.
Discussion
Nos and Pum are translational repressors that are best known for
their roles in early development. Maternal Nos and Pum form a
complex that binds to hb mRNA, which is normally translated
only in the anterior part of the embryo. When Nos or Pum are
absent, Hb protein is made throughout the embryo, and this
produces segmental deletions.
Nos and Pum are required for nervous system development,
and results published previously are consistent with the idea that
they also work together to repress translation in these contexts
(Ye et al., 2004; Muraro et al., 2008). We have focused on the
neuromuscular system, finding phenotypes and targets for Pum
at the larval NMJ (Menon et al., 2004). In this study, we examine
Nos. Nos, like Pum, is expressed in neuronal cell bodies, at the
NMJ, and in the muscles (Fig. 1). However, Nos and Pum have
divergent functions in NMJ development. In nosmutant and neu-
ronal Nos RNAi larvae, the number of boutons at the NMJ is in-
creased,but their size isunaltered(Figs. 2, 3). Incontrast, lossofPum
fromneurons causes a bouton fusionphenotype, so that 1b boutons
are fewer in number andmuch larger (Menon et al., 2004).
Overexpression of Nos in neurons generates a phenotype in
Figure 9. Pum recognizes conserved noncanonical binding sites in the nanos and GluRIIA 3UTRs. A, The sequences of the GluRIIA and nos 405–453 fragments bound by Pum, with nucleotides
conserved between the two indicated in red. The sequences of the GluRIIA GUUA andM2mutants and the nosM1, M2, and M3mutants are shown below the respective wild-type sequences, with
altered nucleotides in green. The lower alignment shows similarity among the Pum-binding regions of the eIF-4E, nos, and GluRIIA 3UTRs. Note that there is a 9 nt sequence spanning theM2motif
that is identical between eIF-4E and nos. B, Gel mobility shift assays of PumRBD binding to 32P-labeled GluRIIAwild-type, GUUA, or M2mutant RNA probes. Binding reactions contained the same
amount of RNA probe and either 0 () or an increasing concentration of PumRBD protein (ramp above lanes). C, UV-crosslinking of the PumRBD to 32P-labeled nos RNA probes. Pum binds to a
fragment encompassingnos3UTRnucleotides 405–453, but not to a fragment containingnucleotides 6–185., Reactionwithout PumRBD;, reaction containingPumRBD.D, Gelmobility shift
assays of PumRBD binding to 32P-labeled nos wild-type, M1, M2, and M3 mutant RNA probes. Binding reactions contained the same amount of RNA probe and either 0 () or an increasing
concentration of PumRBD protein. The Pum-nos RNA complex migrates as a smear of several bands (bracket); the overall intensity of this smear is decreased in the M2 lanes but not for the other
mutants. Note also that the unboundM2mutant probe is not depleted even at the highest concentration of PumRBD, whereas the other probes are. The reason for the differingmobility of the M2
probe is not known but presumably reflects an inherent sequence and/or structural difference. WT, Wild type.
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which the number of AZs in type 1s boutons is reduced (Fig. 3).
Pumneuronal overexpression, however, reduces bouton size and
increases bouton number, so that the NMJ becomes a cluster of
tiny boutons (Menon et al., 2004). The Pum overexpression phe-
notype resembles that seen for loss-of-functionmutants affecting
proteins in endocytic pathways, such as endophilin, synaptoja-
nin, dynamin, and Synaptotagmin (Dickman et al., 2006), sug-
gesting that one or more of these might be neuronal Pum targets.
In pummutants, theGluRIIA subunit of themuscle glutamate
receptor is dramatically upregulated (Menon et al., 2004) (Fig. 8).
In muscle Nos RNAi larvae, however, GluRIIA is downregulated
(Fig. 4), and the levels of the alternative subunit GluRIIB at the
NMJ are increased (Fig. 5). In larvae overexpressing Nos in mus-
cles, GluRIIA levels are increased (Fig. 4). The data suggest that
postsynaptic Nos represses GluRIIB and induces GluRIIA and
that its effects on GluRIIB levels are, at least partially, indepen-
dent of GluRIIA (Fig. 5).
The electrophysiological effects of loss of postsynaptic Nos are
consistent with this model, because mEJP amplitudes are de-
creased, and the spontaneous events have fast decay kinetics (Fig.
6). These are known properties of GluRIIB-containing synapses
(DiAntonio et al., 1999).
PumRBD overexpression causes downregulation of nos
mRNA in neurons (Muraro et al., 2008), and noswas identified as
a PumRBD-boundmRNA in a screen for ovarymRNAs bound to
a tagged Pum protein in vivo (Gerber et al., 2006). Based on these
findings, we examined the relationships betweenNos and Pum in
our system. We found that Nos is a target for Pum repression in
muscles (Fig. 7) and that the PumRBD binds selectively to nos
mRNA in vitro (Fig. 9).
Translational repression by Pum and Nos
In the early embryo, which is a syncytium, Pum is distributed
throughout thecytoplasm,whereasNos is selectively translated from
mRNA localized to the posterior pole. Nos protein diffuses anteri-
orly into the embryo, forming a transient gradient. Pum binds to
NREs in the3UTRofhbmRNA,butNosdoesnotexhibit sequence-
specific RNA binding in the absence of Pum (for review, see Kuer-
sten and Goodwin, 2003). Pum/Nos bound to the hbNRE recruits
Brat, and the Pum/Nos/Brat ternary complex represses translation
of hbmRNA (Sonoda andWharton, 2001).
Pum is a founding member of the PUF family of translational
repressors (for review, see Wickens et al., 2002). PUF proteins
bind to Pop2p and its orthologs (Goldstrohm et al., 2006, 2007;
Kadyrova et al., 2007). Pop2p is a deadenylase and is a compo-
nent of a complex that also includes decapping proteins. The
complex might thus remove all or part of the polyA tail (thereby
destabilizing themRNA) and also remove the cap (thereby block-
ing translational initiation) from any mRNA to which it is re-
cruited by Pum binding. However, this is not sufficient for trans-
lational repression of hb mRNA, since Nos and Brat are also
required.
Pum and Nos also repress translation of CycBmRNA in germ
cells, which do not express Brat. Nos can recruit another subunit
of a deadenylase/decapping complex, NOT4, and artificial teth-
ering ofNos toCycBmRNA in the absence of Pum is sufficient for
repression in germ cells (Kadyrova et al., 2007). These data show
thatNos can repress translationwithout Pum if it is brought to an
mRNA target by another sequence-specific binding protein.
Direct regulation of postsynaptic targets by Pum
eIF-4E is dramatically upregulated at the NMJ in pum mutants.
The 3UTR of eIF-4EmRNA contains a high-affinity Pum bind-
ing site, suggesting that it is a direct repression target (Menon et
al., 2004). eIF-4E is not upregulated in nos mutants, indicating
that Pum affects eIF-4E translation by recruiting other corepres-
sors to themRNA. Similarly, GluRIIA is elevated in pummutants
but is not increased when Nos is knocked down in muscles (Figs.
4, 8). We had originally speculated that GluRIIA upregulation in
pum mutants might be an indirect effect caused by elevation of
postsynaptic eIF-4E. Here, however, we show that Pum also
binds directly to the 3UTR of GluRIIA mRNA (Fig. 8). The
GluRIIAminimal binding region has two Pum sites. One of these
contains the UGUA motif, which is critical for Pum binding to
the hb NRE. The second site, M2, is eliminated by mutations
affecting UGUG, which is found within sites for a different PUF
domain protein, C. elegans FBF (Fig. 9) (Zamore et al., 1999;
Lamont et al., 2004; Bernstein et al., 2005).
Pum also binds directly to the 3UTR of nos mRNA. The nos
minimal binding region does not contain a UGUA, and Pum
binding is reduced by mutation of an M2-like sequence. The M2
sequences in GluRIIA and nos are similar to a sequence in the
eIF-4Eminimal binding region, suggesting that these 3UTR sites
may represent a new type of postsynaptic Pum-binding element
(Fig. 9). However, the nos 3UTR, unlike the eIF-4E andGluRIIA
3UTRs, is likely to be a target for the Pum/Nos repression com-
plex, because Nos protein is upregulated in nosmutants (Fig. 7).
Amodel for regulation of synaptic translation and physiology
by Pum and Nos
The NMJ glutamate receptor is composed of three invariant sub-
units (GluRIIC, GluRIID, and GluRIIE), together with either
GluRIIA or GluRIIB (Marrus et al., 2004; Qin et al., 2005). AnAZ
is associated with clusters of both GluRIIA and GluRIIB subunit-
containing receptors (Rasse et al., 2005; Schmid et al., 2008).
GluRIIA receptors admitmore current in response to transmitter
release than GluRIIB receptors (DiAntonio et al., 1999; Sigrist et
al., 2003; Pawlu et al., 2004). GluRIIA andGluRIIB compete with
each other for occupancy within synaptic receptor complexes, so
that overexpression of the GluRIIB subunit causes a decrease in
the number of GluRIIA-containing receptors at the synapse, and
vice versa (Petersen et al., 1997; DiAntonio et al., 1999; Sigrist et
al., 2002) [but see Schmid et al. (2008) for an alternative view].
When larval motility is induced by a shift from liquid to solid
medium, synaptic strength increases by 40% over a 3 h period.
GluRIIA and postsynaptic eIF-4E are both upregulated during
this time period (Sigrist et al., 2000, 2003). By 24 h later, new
boutons are added to the NMJ. It has been proposed that eleva-
tion of postsynaptic translation in response to the need for in-
creased movement is used to facilitate rapid synaptic growth (Si-
grist et al., 2002). Pum appears to be an upstream component of
this process, because postsynaptic eIF-4E and GluRIIA are dere-
pressed in pummutants even without induction of motility (Me-
non et al., 2004). This suggests that the induction of synaptic
translation and the shift fromGluRIIB to GluRIIA receptors that
occurs in normal larvae in response to increasedmovement could
be triggered by partial inactivation or degradation of Pum.
The regulation ofNos expression by postsynaptic Pum should
amplify the effects on synaptic physiology of a reduction in Pum
activity. This is because reducing Pum both directly derepresses
GluRIIA expression (Fig. 8) and also increases Nos, which re-
presses GluRIIB (Fig. 5). In this manner, a relatively small de-
crease in Pum levels could be amplified into a large change in the
ratio of GluRIIA to GluRIIB in synaptic receptor complexes (Fig.
10). This model leaves open the question of how Nos represses
GluRIIB without Pum. Nos might be recruited to postsynaptic
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mRNA targets by interaction with another sequence-specific
binding protein(s). Alternatively (or in addition), Nos might in-
directly control GluRIIB by regulating signaling pathways that
affect receptor composition or localization.
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